Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Wellness
Home & Realty
Outdoor Guide
Women
Class of 2023
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Services
2023 Readersâ Choice Winners
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by atai Life Sciences
atai Life Sciences to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference
September 14, 2023
From
atai Life Sciences
Via
GlobeNewswire
Tickers
ATAI
atai Life Sciences to Participate in Upcoming September Investor Conferences
September 06, 2023
From
atai Life Sciences
Via
GlobeNewswire
Tickers
ATAI
atai Life Sciences Reports Second Quarter 2023 Financial Results and Operational Highlights, and Announces Clinical Data from the Phase 1 Study of DMX-1002 (Ibogaine)
August 10, 2023
From
atai Life Sciences
Via
GlobeNewswire
Tickers
ATAI
atai Life Sciences Announces Results from the Phase 1 IV-to-Subcutaneous Bridging Study of PCN-101 (R-Ketamine)
August 08, 2023
From
atai Life Sciences
Via
GlobeNewswire
Tickers
ATAI
atai Life Sciences to Participate in Upcoming June Investor Conferences
June 01, 2023
From
atai Life Sciences
Via
GlobeNewswire
Tickers
ATAI
atai Life Sciences Reports First Quarter 2023 Financial Results and Announces Pipeline Highlights and Updates
May 11, 2023
From
atai Life Sciences
Via
GlobeNewswire
Tickers
ATAI
atai Life Sciences to Participate in Upcoming May Investor Conference
May 02, 2023
From
atai Life Sciences
Via
GlobeNewswire
Tickers
ATAI
atai Life Sciences Presents Pharmacodynamic Data on GRX-917 in a Late Breaking Poster Presentation at the 2023 SOBP Annual Meeting
April 28, 2023
From
atai Life Sciences
Via
GlobeNewswire
Tickers
ATAI
atai Life Sciences Announces First Subject Dosed in the Phase 1 IV-to-Subcutaneous Bridging Study of PCN-101 (R-Ketamine)
April 13, 2023
From
atai Life Sciences
Via
GlobeNewswire
Tickers
ATAI
atai Life Sciences Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Clinical Pipeline Highlights
March 24, 2023
From
atai Life Sciences
Via
GlobeNewswire
Tickers
ATAI
atai Life Sciences Announces Key Clinical Pipeline and Corporate Updates
March 06, 2023
From
atai Life Sciences
Via
GlobeNewswire
Tickers
ATAI
atai Life Sciences to Participate in the Cowen 43rd Annual Health Care Conference
March 01, 2023
From
atai Life Sciences
Via
GlobeNewswire
Tickers
ATAI
atai Life Sciences Company GABA Therapeutics Announces Positive Final Results from Phase 1 Single and Multiple Ascending Dose Trial of GRX-917
January 09, 2023
From
atai Life Sciences
Via
GlobeNewswire
Tickers
ATAI
atai Life Sciences Announces Results from Phase 2a Trial of PCN-101 (R-ketamine) for Treatment-Resistant Depression
January 06, 2023
From
atai Life Sciences
Via
GlobeNewswire
Tickers
ATAI
atai Life Sciences Announces Results from the Kures Therapeutics Phase 1 Trial of KUR-101
December 23, 2022
From
atai Life Sciences
Via
GlobeNewswire
Tickers
ATAI
atai Life Sciences Initiates Phase 2b proof-of-concept trial of RL-007 for Cognitive Impairment Associated with Schizophrenia
December 19, 2022
From
atai Life Sciences
Via
GlobeNewswire
Tickers
ATAI
The atai Fellowship Fund in Psychedelic Neuroscience Announces its First Cohort at Massachusetts General Hospital
December 16, 2022
From
atai Life Sciences
Via
GlobeNewswire
Tickers
ATAI
atai Life Sciences Strengthens Leadership Team with Appointment of Dr. Sahil V. Kirpekar as Chief Business Officer
November 29, 2022
From
atai Life Sciences
Via
GlobeNewswire
Tickers
ATAI
atai Life Sciences and Massachusetts General Hospital Announce Initiation of Clinical Study Investigating Neuroplasticity Biomarkers in Treatment-Resistant Depression Patients Undergoing Ketamine Treatment
November 17, 2022
From
atai Life Sciences
Via
GlobeNewswire
Tickers
ATAI
atai Life Sciences Reports Third Quarter 2022 Financial Results and Business Update
November 10, 2022
From
atai Life Sciences
Via
GlobeNewswire
Tickers
ATAI
atai Life Sciences to Participate in November Investor Events & Healthcare Conferences
November 01, 2022
From
atai Life Sciences
Via
GlobeNewswire
Tickers
ATAI
atai Life Sciences to Announce Third Quarter 2022 Financial Results and Business Update
November 01, 2022
From
atai Life Sciences
Via
GlobeNewswire
Tickers
ATAI
atai Life Sciences Company, Perception Neuroscience, Completes Enrollment for Phase 2a Clinical Trial of PCN-101 (R-Ketamine) for Treatment-Resistant Depression
October 25, 2022
From
atai Life Sciences
Via
GlobeNewswire
Tickers
ATAI
atai Life Sciences Announces R&D Day Agenda
October 20, 2022
From
atai Life Sciences
Via
GlobeNewswire
Tickers
ATAI
atai Life Sciences Announces Initiation of Phase 1 Proof-of-Concept Clinical Trial for Its Sol-gel Based Direct-to-Brain Drug Delivery Technology
October 18, 2022
From
atai Life Sciences
Via
GlobeNewswire
Tickers
ATAI
atai Life Sciences Announces Positive Initial Results for Phase 1 Trial of KUR-101, an Oral Formulation of Mitragynine for OUD
October 12, 2022
From
atai Life Sciences
Via
GlobeNewswire
Tickers
ATAI
atai Life Sciences Announces First Subject Dosed in Phase 1 Trial of Buccal and IV VLS-01, a Synthetic Form of DMT
October 05, 2022
From
atai Life Sciences
Via
GlobeNewswire
Tickers
ATAI
atai Life Sciences to Participate in October Investor Events & Host Virtual R&D Day
October 04, 2022
From
atai Life Sciences
Via
GlobeNewswire
Tickers
ATAI
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.